
Qiming-Backed AI Drug Discovery Startup Insilico Medicine Hits Unicorn Status With $110 Million Funding Round
Alex Zhavoronkov, founder and co-CEO of Insilico Medicine. Insilico Medicine Insilico Medicine, an AI drug discovery company based in Hong Kong and Boston, has joined the unicorn club after raising $110 million in a funding round led by Hong Kong- …